Results
|
|
41.
|
|
|
|
42.
|
|
|
|
43.
|
|
|
|
44.
|
|
|
|
45.
|
|
|
|
46.
|
|
|
|
47.
|
|
|
|
48.
|
|
|
|
49.
|
|
|
|
50.
|
|
|
|
51.
|
|
|
|
52.
|
|
|
|
53.
|
|
|
|
54.
|
|
|
|
55.
|
|
|
|
56.
|
|
|
|
57.
|
|
|
|
58.
|
|
|
|
59.
|
|
|
|
60.
|
A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy. [electronic resource] by
- Antman, K
- Ayash, L
- Elias, A
- Wheeler, C
- Hunt, M
- Eder, J P
- Teicher, B A
- Critchlow, J
- Bibbo, J
- Schnipper, L E
Producer: 19920127
In:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 10
Availability: No items available.
|